Medicines for human use
Medicines for Human Use (Clinical Trials Regulations) Informed consent in clinical trials
... The Medicines for Human Use (Clinical Trials) and Blood Safety and Quality Amendment) Regulations 2008 made additional provision relating to trials involving minors in emergency ...
15
Applications for new human medicines under evaluation by the Committee for Medicinal Products for Human Use
... for human medicines that the European Medicines Agency has received for ...innovative medicines under evaluation by the Committee for Medicinal Products for Human Use ...
5
PROFESSIONAL INFORMATION FOR MEDICINES FOR HUMAN USE
... Severe hypomagnesaemia has been reported with the use of PPIs like lansoprazole, as contained in ASPEN LANSOPRAZOLE for at least three months and in most cases for a year. Serious manifestations of hypomagnesaemia ...
19
Medicines for Human Use (Clinical Trials Regulations) 2004
... 19. Generally speaking, members who are not eligible to be lay members will meet one of the criteria in paragraph 11 above and will therefore be eligible for appointment as expert members. There may however be some ...
8
DESCRIPTION OF THE MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004
... proper use of the ...for medicines dispensed by pharmacists, and are to be used in a clinical trial on patients for which the product is indicated in that ...
17
2 Medicines for Human Use: Controlled Drugs & Accountable Officer Regulations
... 2. Requisitions: i.e., whether a requisition is necessary before supply may be made to practitioners, persons in charge of hospitals, masters of ships. etc. From January 1st 2008, for requisitions (other than veterinary ...
30
The European Union regulatory network incident management plan for medicines for human use
... European Medicines Agency’s Crisis Management Plan for Centrally Authorised Products (CAPs) 1 , which became effective in September 1997, the need was identified to not only revise such Crisis Management Plan to ...
20
PROFESSIONAL INFORMATION FOR MEDICINES FOR HUMAN USE. Lactose monohydrate, magnesium stearate, maize starch, povidone.
... Massive absorption of ZYLOPRIM may lead to considerable inhibition of xanthine oxidase activity, which should have no untoward effects unless 6-mercaptopurine and/or azathioprine is being taken concomitantly. In this ...
8
2000 No MEDICINES. The Prescription Only Medicines (Human Use) Amendment Order 2000
... the Medicines Act 1968(a) or, as the case may be, those conferred by the said provisions and now vested in them(b), and of all other powers enabling them in that behalf, after consulting such organisations as ...
10
Applications for new human medicines under evaluation by the Committee for Medicinal Products for Human Use
... for medicines whose applications have been validated at the time the report was ...orphan medicines that are being assessed for marketing authorisation is also available in the monthly reports of the ...
5
Applications for new human medicines under evaluation by the Committee for Medicinal Products for Human Use
... for medicines whose applications have been validated at the time the report was ...orphan medicines that are being assessed for marketing authorisation is also available in the monthly reports of the ...
5
European Medicines Agency policy on publication of clinical data for medicinal products for human use
... development more efficient by establishing a level playing field that allows all medicine developers to learn from past successes and failures. Furthermore, it will enable the wider scientific community to make ...
22
The Human Medicines Regulations 2012
... for human use which is imported from a state other than an EEA State, handled, stored or distributed under the licence is not false or misleading in a material ...
322
European Medicines Agency recommends restricting use of trimetazidine-containing medicines
... European Medicines Agency completed a review of the safety and effectiveness of trimetazidine following concerns over its effectiveness and reports of movement disorders such as parkinsonian symptoms with these ...
9
One-year report on human medicines pharmacovigilance tasks of the European Medicines Agency
... 6.3.1.6. ADR reporting, monitoring and management (EudraVigilance) The new PhV legislation included a strengthened role for the EudraVigilance database as the single point of receipt of all suspected ADRs by MSs and ...
44
PROPOSALS FOR AMENDMENTS TO THE HUMAN MEDICINES REGULATIONS 2012 TO ALLOW WIDER ACCESS TO NALOXONE FOR USE IN EMERGENCIES
... the Medicines Act 1968 about a proposal to allow wider access to naloxone for the purpose of saving life in an ...the Human Use Regulations ...the Medicines and Healthcare products Regulatory ...
9
HUMAN MEDICINES. Generic medicines. Our advice
... Are there any circumstances or situations when I shouldn’t use generic medicines? Yes. For a small number of products, it is not advisable to take different versions of the medicine. This is because your ...
5
Widespread use of herbal medicines by people living with human immunodeficiency virus and contamination of herbal medicines with antiretrovirals in Nigeria.
... We found 2% of herbal medicines contained small, but detectable quantities of ARVs, yielding an estimat- ed dose of 0.1–1.3 mg ingested per dosing occasion. The clinical relevance of this is unclear. However, ...
8
Collection, Access and Use of Human Genetic Information for Precision Medicines: Risk Governance Considerations
... Regulators, industry and patients can work together to establish a clear link between personal and public health benefits. If some individuals benefit from early precision medicine, they also, at the same time, ...
16
2 Human medicines: scope of regulation
... the use of a medicinal product in a timely man- ner, through publication on the UK web portal, and through other means of publicly available information as necessary; ...
17